Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.145 USD -2.02% Market Closed
Market Cap: 33.9m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Lowest
Price Target
18.18 USD
478% Upside
Average
Price Target
22.44 USD
614% Upside
Highest
Price Target
27.3 USD
768% Upside
Lantern Pharma Inc. Competitors:
Price Targets
RXRX
Recursion Pharmaceuticals Inc
67% Upside
1801
Innovent Biologics Inc
65% Upside
MRUS
Merus NV
111% Upside
397030
AprilBio Co Ltd
93% Upside
IDYA
IDEAYA Biosciences Inc
118% Upside
302440
SK Bioscience Co Ltd
8% Downside
ABBV
Abbvie Inc
20% Upside
LGND
Ligand Pharmaceuticals Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Back to Top